Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1751

-0.0042

-0.35%

GBP/USD

1.3189

-0.0057

-0.43%

USD/JPY

112.39

0.2160

0.19%

USD/CHF

0.9792

0.0037

0.38%

EUR/GBP

0.8910

0.0007

0.08%

USD/CAD

1.2540

0.0021

0.16%

NZD/USD

0.7166

-0.0020

-0.28%

EUR/JPY

132.06

-0.2115

-0.16%

EUR/CHF

1.1506

0.0003

0.02%

Infinity Pharmaceuticals Inc.

NASDAQ: INFIHealthcare / Biotechnology / USA
2.95+0.05+1.72%Vol 4 731 1381Y Perf 110.71%
Oct 16th, 2017 16:00
BID2.95 ASK3.01
Open3.04 Previous Close2.90
Pre-Market2.97 After-Trading3.00
 0.02 0.68%  0.05 1.69%
Target Price
1.75 
Analyst Rating
Moderate Buy 2.50
Potencial %
-40.68 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/63 
Value Ranking
★+     44.63
Insiders Value % 3/6/12M
-/-/89 
Growth Ranking
+     32.39
Insiders Shares Cnt. % 3/6/12M
-/-/90 
Income Ranking
 —    -
Market Cap (mil)150 
Earnings Rating
Price Range Ratio 52wk %
70.33 
Earnings Date
7th Nov 2017

Today's Price Range

2.663.14

 

52wk Range

0.843.84

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
130.47%
3 Months
113.77%
6 Months
60.33%
1 Year
110.71%
3 Years
-77.72%
5 Years
-88.34%
Last Quotes
Name / TickerPriceChg.Chg.%
INFI2.950.05001.72
AAPL159.882.89001.84
GOOG992.002.32000.23
MSFT77.650.16000.21
XOM82.810.40000.49
WFC53.800.11000.20
JNJ136.12-0.3100-0.23
FB174.520.78000.45
GE23.360.38001.65
JPM97.841.98002.07
...

TickerPriceChg.%52 Week High
DVA56.934.0270.16
FCX15.273.5317.06
WYNN146.813.15150.40
NBL27.902.7642.03
APA42.732.7269.00
MU41.492.7042.07
HES46.042.3365.56
DFS65.352.3074.33
SYF31.502.2138.06
NRG26.622.1526.68
JPM97.842.0797.95
AMAT55.042.0455.09
BWA52.172.0352.71
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 6.10
Current Ratio 6.30
Long Term Debt to Total Capital 0.21
Total Debt to Equity 0.26
Interest Coverage -56.70
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-102.50
EBITDA Margin-96.20
Pre-tax Profit Margin-
Profit Margin-19.81
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.50
PS Ratios 9.64
Price to Cash Flow 8.50
Price to Free Cash Flow -3.10
Cash Flow Per Share -1.65
Price to Tangible Book2.50
Book Value per Share1.16
Enterprise Value (in ths.)80 803
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-42.63
ROE last 12 Months -76.86
Return on Assets (5Y Avg) -47.45
ROA last 12 Months -49.11
Return on Capital (5Y Avg) -35.59
ROC last 12 Months -76.97
Return on invested Capital Q -25.10
Return on invested Capital Y-26.18
Assets Turnover0.00
Receivables Turnover1.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2017-0.22-0.34-54.55
Q01 2017-0.22-0.214.55
Q04 2016--0.46-
Q03 2016-0.84-0.3953.57
Q02 2016-0.89-0.4351.69
Q01 2016-0.86-0.824.65
Q04 2015-0.83-0.803.61
Q03 2015-0.760.84210.53
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.214.55Positive
12/2017 QR-0.220.00-
12/2017 FY-0.98-10.11Negative
12/2018 FY-0.9337.58Positive
Next Report Date7th Nov 2017
Estimated EPS Next Report-0.21
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume4 731 138
Shares Outstanding (in ths.)50 690
Trades Count10 271
Dollar Volume13 256 555
Avg. Volume1 334 918
Avg. Weekly Volume16 991 912
Avg. Monthly Volume5 411 588
Avg. Quarterly Volume2 205 912

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

89%11%

Bearish Bullish

100%0%

Bearish Bullish

62%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (25.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (75.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.50
Hold
3.00
Hold
3.00

There are no comments yet.

News

x